Elevation Oncology, Inc.

ELEV · NASDAQ
Analyze with AI
3/31/2025
12/31/2024
9/30/2024
6/30/2024
Operating Activities
Net Income-$14-$10-$13-$10
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$1$1$1
Change in WC$1-$1$4$1
Other Non-Cash-$0-$0-$0-$0
Operating Cash Flow-$13-$10-$8-$8
Investing Activities
PP&E Inv.$0$0-$8$8
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$9-$14-$47
Inv. Sales/Matur.$24$21$11$9
Other Inv. Act.$0$0$8-$8
Investing Cash Flow$24$11-$3-$38
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$15
Stock Repurch.-$0-$0-$0-$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$0-$0$0$15
Forex Effect$0$0$0$0
Net Chg. in Cash$11$1-$11-$31
Supplemental Information
Beg. Cash$49$48$59$91
End Cash$60$49$48$59
Free Cash Flow-$13-$10-$8$0
Elevation Oncology, Inc. (ELEV) Financial Statements & Key Stats | AlphaPilot